Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: Influence of comorbidity, age, and sex on specificity and threshold values

Clinical Chemistry

Volumn 45, Issue 12, 1999, Pages 2269-2272

  Batstra, Manou R ^a,g   Van Driel, Arianne ^a   Petersen, Jacob S ^b   Van Donselaar, Cees A ^a,e   Van Tol, Maarten J ^c   Bruining, G Jan ^a   Grobbee, Diederick E ^a   Dyrberg, Thomas ^d   Aanstoot, Henk Jan ^a,f  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NOVO NORDISK A S   (Denmark)

^e Afd Klinische Pathologie   (Netherlands)

^f IJSSELLAND HOSPITAL   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CHILD; COMORBIDITY; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; EPILEPSY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OVARY DISEASE;

EID: 0032754033     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.12.2269     Document Type: Article

References (23)

1. 1. Aanstoot HJ, Kang SM, Kim J, Lindsay LA, Roll U, Knip M, et al. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Investig 1996;97:2772-83.
2. 2. Batstra MR, Bruining GJ, Aanstoot HJ. Antibody screening in a population of children. Ann Med 1997;29:453-60.
3. 3. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997;46:1701-10.
4. 4. Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Bohm BO, Richter W. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes 1997;46:565-71.
5. 5. Kulmala P, Savola K, Petersen JS, Vahasalo P, Karjalainen J, Lopponen T, et al. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Investig 1998;101:327-36.
6. 6. Roll U, Ziegler AG. Combined antibody screening for improved prediction of IDDM-modern strategies. Exp Clin Endocrinol Diabetes 1997;105:1-14.
7. 7. Seissler J, de Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, et al. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia 1998;41:891-7.
8. 8. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Investig 1993;91:368-74.
9. 9. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994;11:299-303.
10. 10. Borg H, Fernlund P, Sundkvist G. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus. Clin Chem 1997;43: 2358-63.
11. 11. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993;42:359-62.
12. 12. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MIJ. GAD antibodies in NIDDM: ten-year follow-up from the diagnosis. Diabetes Care 1995; 18:1557-65.
13. 13. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994;43:459-67.
14. 14. Kim J, Namchuk M, Buchawan T, Fu Q, Jaffe M, Shi Y, et al. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin dependent diabetes mellitus. J Exp Med 1994;180:595-606.
15. 15. Celotti F, Moore GD, Rovescalli AC, Solimena M, Negri-Cesi P, Racagni G. The GABAergic system in the rat oviduct: presence, endocrine regulation and possible localization. Pharmacol Res 1989;21:103-4.
16. 16. Erdo SL, Joo F, Wolff JR. Immunohistochemical localization of glutamate decarboxylase in the rat oviduct and ovary: further evidence for non-neural GABA systems. Cell Tissue Res 1989;255:431-4.
17. 17. De Man SA, Andre JL, Bachmann H, Grobbee DE, Ibsen KK, Laaser U, et al. Blood pressure in childhood: pooled findings of six European studies. J Hypertens 1991;9:109-14.
18. 18. Ruwaard D, Hirasing RA, Reeser HM, Van Buuren S, Bakker K, Heine RJ, et al. Increasing incidence of type I diabetes in The Netherlands. The second nationwide study among children under 20 years of age. Diabetes Care 1994;17:599-601.
19. 19. Stroink H, Brouwer OF, Arts WF, Geerts AT, Peters AC, Van Donselaar CA. The first unprovoked, untreated seizure in childhood: a hospital based study of the accuracy of the diagnosis, rate of recurrence, and long term outcome after recurrence. Dutch study of epilepsy in childhood. J Neurol Neurosurg Psychiatry 1998;64:595-600.
20. 20. Carpay H, Arts WFM, Geerts H, Brouwer OF, Peters ACB, Donselaar CAV. Epilepsy in childhood. An audit of clinical practice. Arch Neurol 1998;55: 668-73.
21. 21. Hoes AW, Grobbee DE, Valkenburg HA, Lubsen J, Hofman A. Cardiovascular risk and all-cause mortality: a 12 years follow-up study in The Netherlands. Eur J Epidemiol 1993;9:285-92.
22. 22. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347:151-6.
23. 23. Vandewalle CL, Falorni A, Svanholm S, Lernmark A, Pipeleers DG, Gorus FK. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry. J Clin Endocrinol Metab 1995;80:846-51.